Condition
Kidney Transplant; Complications
ClinicalTrials.gov condition label
Clinical trials
22 shownVascular Complications After Kidney TransplantationNCT07531966 · 2026-05-22
RECRUITINGThe EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR StudyNCT06059664 · 2024-04-23
RECRUITINGEfficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant RecipientsNCT06140537 · 2024-02-01
RECRUITINGEffect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes MellitusNCT06095492 · 2023-10-30
RECRUITINGUse of CGM in Kidney Transplant RecipientsNCT04783441 · 2021-06-29
RECRUITINGStOPping Hypertension and imprOving Children's Lives After KidnEy TranSplantationNCT06589947 · 2024-09-16
NOT_YET_RECRUITINGFeasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) ProgramNCT06688825 · 2024-09-16
COMPLETEDEmpagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes MellitusNCT06098625 · 2023-11-10
UNKNOWNDefine Predictors for Posttransplant Diabetes Mellitus StudyNCT06440330 · 2023-09-01
UNKNOWNContinuous Glucose Monitoring (CGM) in Kidney-Transplanted AdultsNCT05352230 · 2023-04-15
TERMINATEDHome Blood Pressure Monitoring in Kidney Transplant RecipientsNCT04364126 · 2022-12-15
TERMINATEDCardioRenal Effects of SGLT2 Inhibition in Kidney Transplant RecipientsNCT04906213 · 2022-07-25
TERMINATEDDietary Intervention to Improve Kidney Transplant OutcomesNCT05449496 · 2022-06-27
ACTIVE_NOT_RECRUITINGHHV8 and Solid Organ TransplantationNCT05081141 · 2021-09-15
UNKNOWNAZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNceNCT05216172 · 2019-12-13
COMPLETEDThe POWERED Study: Prophylaxis With Metformin to Prevent PTDMNCT05240274 · 2019-01-25
COMPLETEDEfficacy and Safety of Empagliflozin in NODATNCT03642184 · 2018-07-14
TERMINATEDThe wEight Management in Renal Transplant Online Study (ExeRTiOn)NCT03699059 · 2018-05-31
COMPLETEDEffect of Dietary Salt Reduction on Blood Pressure in Kidney Transplant RecipientsNCT03373500 · 2017-10-11
UNKNOWNProject LIFT - Promoting Healthy Behavior Through a Wearable Fitness Device and Financial IncentivesNCT03221465 · 2017-03-01
COMPLETEDSPRINT Trial Type Blood Pressure Measurements in Patients After Kidney TransplantationNCT03094702 · 2017-01-01
COMPLETEDIncisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled TrialNCT03010137 · 2015-12-01
TERMINATEDCommon interventions
PlaceboDRUG5Empagliflozin 25 MGDRUG2LinagliptinDRUG2AZD1656DRUG1Blood drawBIOLOGICAL1Catheter-based angiographyDIAGNOSTIC_TEST1Clinic blood pressureOTHER1continuous glucose monitoringDEVICE1Dapagliflozin 10mg TabDRUG1DermabondDEVICE1Dexcom G6DEVICE1Dexcom G6 blinded sensorDEVICE1Diagnostic test for HHV8 exposureDIAGNOSTIC_TEST1Dietary Education CurriculumBEHAVIORAL1Dietary salt reductionOTHER1Education regarding Weight lossBEHAVIORAL1EmpagliflozinDRUG1Empagliflozin10Mg TabDRUG1ExeRTiOnOTHER1Finerenone Oral TabletDRUG1Free style libre-2DEVICE1Home blood pressure apparatusDEVICE1Incisional Negative Pressure Wound TherapyPROCEDURE1Intensified BP controlOTHER1Intravascular ultrasound (IVUS)DIAGNOSTIC_TEST1
Leading sponsors
University of California, Davis3Medanta, The Medicity, India2Barts & The London NHS Trust1Duke University1Epsom and St Helier University Hospitals NHS Trust1Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1Hannover Medical School1King's College Hospital NHS Trust1Martin-Luther-Universität Halle-Wittenberg1Oslo University Hospital1Queen Mary University of London1RenJi Hospital1University Hospital, Antwerp1University of Aarhus1University of Alabama at Birmingham1
Trial status mix
COMPLETED6
RECRUITING5
TERMINATED5
UNKNOWN4
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
Phase mix
NA12
PHASE24
PHASE42
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.